Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 16/20 | 0.55 |
| ▸ | CTSK | P43235 | 15/20 | 0.55 |
| ▸ | CTSS | P25774 | 12/20 | 0.55 |
| ▸ | CTSB | P07858 | 11/20 | 0.55 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14673197 | 0.93 | CTSK (0.55) | CTSLCTSKCTSSCTSBCTSF | |
| SCHEMBL14673525 | 0.89 | CTSK (0.55) | CTSLCTSKCTSSCTSB | |
| SCHEMBL2155014 | 0.86 | CTSK (0.71) | CTSLCTSKCTSSCTSB | |
| SCHEMBL14673246 | 0.86 | CTSK (0.55) | CTSLCTSKCTSSCTSB | |
| SCHEMBL6363596 | 0.83 | CTSK (0.60) | CTSLCTSKCTSSCTSB | |
| SCHEMBL14672972 | 0.82 | CTSK (0.59) | CTSLCTSKCTSSCTSBCTSF | |
| SCHEMBL2156497 | 0.78 | CTSK (0.70) | CTSLCTSKCTSSCTSB | |
| SCHEMBL13906546 | 0.77 | CTSK (0.55) | CTSLCTSKCTSSCTSB | |
| SCHEMBL4679661 | 0.75 | CTSK (0.59) | CTSLCTSKCTSSCTSBCTSF | |
| SCHEMBL2156139 | 0.75 | CTSK (0.59) | CTSLCTSKCTSSCTSBCTSF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130035312-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBIORS | AXYS PHARMACEUTICALS, INC. (US) | 2013-02-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035312-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBIORS | CTSB, CTSS, CTSZ | CTSL 8/4885CTSK 4/4885CTSS 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.